Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : KOOL - ThermoGenesis Corp. -- Ignore unavailable to you. Want to Upgrade?

To: Evan Dimmer who wrote (7)	4/29/1998 9:03:00 AM
From: Evan Dimmer	Read Replies (1) \| Respond to of 13

YEAH, THIS COULD BE GOOD!!!!!! Wednesday April 29, 7:30 am Eastern Time Company Press Release SOURCE: Thermogenesis Corp. THERMOGENESIS CORP. Receives Permission from the Medical Devices Bureau of Health Canada to Sell Hand-Held Fibrin Sealant Applicators in Canada RANCHO CORDOVA, Calif., April 29 /PRNewswire/ -- THERMOGENESIS CORP. (Nasdaq: KOOL - news) today announced that it has received permission from the Medical Devices Bureau of Health Canada to begin selling their hand-held, disposable fibrin sealant applicators in Canada. These precision applicators, which will sell for approximately US$40, were designed to be used with THERMOGENESIS CORP.'s CryoSeal(TM) System, which received Health Canada clearance to market in January 1998. The CryoSeal System provides rapid automated harvesting of adhesive and clotting proteins from donor plasma to produce Cryoprecipitated AHF (''Cryo''), an FDA-licensed biological product for the treatment of hemophilia. Normally prepared by blood banks in a two-day, handling-intensive process, Cryo has been used by U.S. surgeons as an ''off-label'' fibrin glue, a biological sealant used to stop bleeding and augment or replace sutures in surgical operations. The Company estimates that Cryo is used in more than 500,000 surgical procedures annually by U.S. and Canadian surgeons. James H. Godsey, PhD, the Company's President and Chief Operating Officer stated that ''obtaining permission from the Canadian Medical Devices Bureau is an important milestone in THERMOGENESIS' efforts to establish our Cryo applicators as the global market leader in fibrin-glue based surgical procedures.'' Dr. Godsey also noted that ''this is yet another exciting milestone for our CryoSeal System, following the recent appointments of Dideco, S.p.A., Mirandola, Italy, as the exclusive distributor for the CryoSeal System and fibrin sealant applicators in Europe and Asahi Medical Co., Ltd. for distribution in Japan.'' Based in Rancho Cordova, California, THERMOGENESIS CORP. has been a pioneer in designing, manufacturing and distributing ultra rapid freezers and thawers for blood products and biological tissues. Additional information about the Company can be obtained from its web site at www.thermogenesis.com The statements contained in this release which are not historical facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond the Company's control with respect to market acceptance of new technologies and products, delays in testing and evaluation of products, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission. SOURCE: Thermogenesis Corp.